EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective

Chunming Wang, Lei Cai, Qingyu Xie, Cheng Zhang, Xuefang Chen, Peng Cui, Guoqiang Wang, Shangli Cai, Yusheng Han, Kaihang Zhong, Guolin He, Shunjun Fu und 3 weitere

Cancer Reports · 2025

DOI: 10.1002/cnr2.70300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Chunming Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Gua…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antigens, Neoplasm, Biomarkers, Tumor. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2018 Entrepreneurial Leading Talent of Guangzhou Huangpu District and Guangzhou Development District, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunotherapies including immune checkpoint inhibitors and tumor antigen based vaccines have revolutionized cancer treatment. However, immune signatures of hepatocellular carcinoma (HCC) have not been thoroughly studied from a multiomics perspective.

Aims

In this study, we aimed to identify the potential tumor antigens and immune subtyping for HCC using multiomics data. Methods and Results The study included 159 HCC patients with genome, transcriptome, proteome, and phosphoproteome data. Two potential tumor antigens, ZNF831 and SYNE1, showed significant superior prognostic effects and positive correlations with antigen presenting cells, which provided promising candidates for the development of tumor antigen‐based mRNA vaccine. A multiomics clustering using the most variable tumor antigen genes of transcriptome, proteome, and phosphoproteome was performed, resulting in two HCC subtypes with distinct clinical and molecular features. In order to further explore the complex tumor microenvironment, we implemented an immune subtyping using 30 most important immune‐related features generated from the random forest algorithm. Four immune subtypes were constructed, which exhibited diverse molecular attributes including immune cell activities, angiogenesis, cell proliferation, and the expression of tumor antigen genes, immune checkpoints, and immunogenic cell death modulators.

Conclusion

In summary, we found two potential tumor antigens, ZNF831 and SYNE1, and identified four immune subtypes of HCC with distinct molecular features. Our study provides novel insights into the development of cancer vaccine and precision medicine of immune oncology in HCC, which may benefit clinical practice in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntigens, NeoplasmBiomarkers, TumorHumansTumor MicroenvironmentPrognosisNuclear ProteinsMaleFemaleProteomicsTranscriptomeNerve Tissue ProteinsGene Expression ProfilingMiddle AgedGene Expression Regulation, NeoplasticMultiomics

Stichwörter der Autor:innen

hepatocellular cancerimmune subtypemultiomicstumor antigens

Substanzen

Antigens, NeoplasmBiomarkers, TumorNuclear ProteinsNerve Tissue Proteins

Autor:innen und Institutionen

  • General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Live…
  • Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Burning Rock Biotech, Guangzhou, China.

ORCID-Profile: Mingxin Pan

Förderung

  • 2018 Entrepreneurial Leading Talent of Guangzhou Huangpu District and Guangzhou Development District
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation of China

Zitieren

APA

Wang, C., Cai, L., Xie, Q., Zhang, C., Chen, X., Cui, P., Wang, G., Cai, S., Han, Y., Zhong, K., He, G., Fu, S., Xu, Y., He, J., & Pan, M. (2025). Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective. Cancer Reports. https://doi.org/10.1002/cnr2.70300

Vancouver

Wang C, Cai L, Xie Q, Zhang C, Chen X, Cui P, et al. Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective. Cancer Reports. 2025. doi:10.1002/cnr2.70300

BibTeX
@article{Wang2025,
  author = {Wang, Chunming and Cai, Lei and Xie, Qingyu and Zhang, Cheng and Chen, Xuefang and Cui, Peng and Wang, Guoqiang and Cai, Shangli and Han, Yusheng and Zhong, Kaihang and He, Guolin and Fu, Shunjun and Xu, Yuyan and He, Junming and Pan, Mingxin},
  title = {Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70300}
}
Kostenlos starten →